Cann Group Limited, based in Victoria, Australia, is the first company in the country that gets a license to grow and harvest medicinal cannabis, after the application had been approved by the Drug Control Service of the Ministry of Health.
The Health Bureau said that the permits initially only will be reserved and issued for the Victorian market but also that it intends to grant licenses to other regions soon.
The government is committed to facilitate faster access to specialist physicians with experience in medical cannabis and to facilitate the necessary approvals for patients. The strict rules safeguarding the project will ensure the safety of every individual and the community.
This heralds the beginning of the prescription of medicinal products in Australia. Cann Group is building an Australian business of world class to take advantage of the opportunities and benefits that the cannabis industry offers.
The pharmaceutical company has built relationships with organizations in Australia and overseas that can provide elite plant genetics. Which at the same time will allow it to participate in breeding programs, and the development of drugs based on cannabis oil of consistent quality.
Cann has extensive experience in the agro-food, biotechnology and pharmaceutical industries, as well as entrepreneurship and business development.